Cargando…
The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment
Opioid dependence is largely an undertreated medical condition in the United States. The introduction of buprenorphine has created the potential to expand access to and use of opioid agonist treatment in generalist settings. Physicians, however, often have limited training and experience providing t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917666/ https://www.ncbi.nlm.nih.gov/pubmed/20458550 http://dx.doi.org/10.1007/s11606-010-1377-y |
_version_ | 1782185087252561920 |
---|---|
author | Egan, James E. Casadonte, Paul Gartenmann, Tracy Martin, Judith McCance-Katz, Elinore F. Netherland, Julie Renner, John A. Weiss, Linda Saxon, Andrew J. Fiellin, David A. |
author_facet | Egan, James E. Casadonte, Paul Gartenmann, Tracy Martin, Judith McCance-Katz, Elinore F. Netherland, Julie Renner, John A. Weiss, Linda Saxon, Andrew J. Fiellin, David A. |
author_sort | Egan, James E. |
collection | PubMed |
description | Opioid dependence is largely an undertreated medical condition in the United States. The introduction of buprenorphine has created the potential to expand access to and use of opioid agonist treatment in generalist settings. Physicians, however, often have limited training and experience providing this type of care. Some physicians believe having a mentoring relationship with an experienced provider during their initial introduction to the use of buprenorphine would ease implementation. Our goal was to describe the development, implementation, resources, and evaluation of the Physician Clinical Support System-Buprenorphine (PCSS-B), a federally funded program to improve access to and quality of treatment with buprenorphine. We provide a description of the PCSS-B, a national network of 88 trained physician mentors with expertise in buprenorphine treatment and skills in clinical education. We provide information regarding the use the PCSS-B core services including telephone, email and in-person support, a website, clinical guidances, a warmline and outreach to primary care and specialty organizations. Between July 2005 and July 2009, 67 mentors and 4 clinical experts reported providing mentoring services to 632 participants in 48 states, Washington DC and Puerto Rico. A total of 1,455 contacts were provided through email (45%), telephone (34%) and in-person visits (20%). Seventy-six percent of contacts addressed a clinical issue. Eighteen percent of contacts addressed a logistical issue. The number of contacts per participant ranged from 1–125. Between August 2005 and April 2009 there were 72,822 visits to the PCSS-B website with 179,678 pages viewed. Seven guidances were downloaded more than 1000 times. The warmline averaged more than 100 calls per month. The PCSS-B model provides support for a mentorship program to assist non-specialty physicians in the provision of buprenorphine and may serve as a model for dissemination of other types of care. |
format | Text |
id | pubmed-2917666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-29176662010-10-07 The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment Egan, James E. Casadonte, Paul Gartenmann, Tracy Martin, Judith McCance-Katz, Elinore F. Netherland, Julie Renner, John A. Weiss, Linda Saxon, Andrew J. Fiellin, David A. J Gen Intern Med Original Research Opioid dependence is largely an undertreated medical condition in the United States. The introduction of buprenorphine has created the potential to expand access to and use of opioid agonist treatment in generalist settings. Physicians, however, often have limited training and experience providing this type of care. Some physicians believe having a mentoring relationship with an experienced provider during their initial introduction to the use of buprenorphine would ease implementation. Our goal was to describe the development, implementation, resources, and evaluation of the Physician Clinical Support System-Buprenorphine (PCSS-B), a federally funded program to improve access to and quality of treatment with buprenorphine. We provide a description of the PCSS-B, a national network of 88 trained physician mentors with expertise in buprenorphine treatment and skills in clinical education. We provide information regarding the use the PCSS-B core services including telephone, email and in-person support, a website, clinical guidances, a warmline and outreach to primary care and specialty organizations. Between July 2005 and July 2009, 67 mentors and 4 clinical experts reported providing mentoring services to 632 participants in 48 states, Washington DC and Puerto Rico. A total of 1,455 contacts were provided through email (45%), telephone (34%) and in-person visits (20%). Seventy-six percent of contacts addressed a clinical issue. Eighteen percent of contacts addressed a logistical issue. The number of contacts per participant ranged from 1–125. Between August 2005 and April 2009 there were 72,822 visits to the PCSS-B website with 179,678 pages viewed. Seven guidances were downloaded more than 1000 times. The warmline averaged more than 100 calls per month. The PCSS-B model provides support for a mentorship program to assist non-specialty physicians in the provision of buprenorphine and may serve as a model for dissemination of other types of care. Springer-Verlag 2010-05-11 2010-09 /pmc/articles/PMC2917666/ /pubmed/20458550 http://dx.doi.org/10.1007/s11606-010-1377-y Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Research Egan, James E. Casadonte, Paul Gartenmann, Tracy Martin, Judith McCance-Katz, Elinore F. Netherland, Julie Renner, John A. Weiss, Linda Saxon, Andrew J. Fiellin, David A. The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment |
title | The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment |
title_full | The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment |
title_fullStr | The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment |
title_full_unstemmed | The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment |
title_short | The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment |
title_sort | physician clinical support system-buprenorphine (pcss-b): a novel project to expand/improve buprenorphine treatment |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917666/ https://www.ncbi.nlm.nih.gov/pubmed/20458550 http://dx.doi.org/10.1007/s11606-010-1377-y |
work_keys_str_mv | AT eganjamese thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT casadontepaul thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT gartenmanntracy thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT martinjudith thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT mccancekatzelinoref thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT netherlandjulie thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT rennerjohna thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT weisslinda thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT saxonandrewj thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT fiellindavida thephysicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT eganjamese physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT casadontepaul physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT gartenmanntracy physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT martinjudith physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT mccancekatzelinoref physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT netherlandjulie physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT rennerjohna physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT weisslinda physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT saxonandrewj physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment AT fiellindavida physicianclinicalsupportsystembuprenorphinepcssbanovelprojecttoexpandimprovebuprenorphinetreatment |